I
INCR
vs
S&P 500
S&P 500
Over the past 12 months, INCR has underperformed S&P 500, delivering a return of -50% compared to the S&P 500's +18% growth.
Stocks Performance
INCR vs S&P 500
Performance Gap
INCR vs S&P 500
Performance By Year
INCR vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
InterCure Ltd
Glance View
InterCure Ltd. engages in the business of medical cannabis and biomedicine. Thorugh its wholly owned subsidiary Canndoc the Company operates as licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products.